Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008, 58(2): 71-96. [2]Lee J W, Choi C H, Choi J J, et al. Altered MicroRNA expression in cervical carcinomas[J]. Clin Cancer Res, 2008, 14 (9): 2535-2542.？ [3]Bosco N, Pelliccia F, Rocchi A. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region[J]. Cancer Genet Cytogenet, 2010, 202(1): 47-52. [4]Vickers M M, Bar J, Gorn-Hondermann I, et al. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease[J]. Clin Exp Metastasis, 2012, 29(2): 123-132.？ [5]罗学群, 徐令, 柯志勇, 等. 儿童急性粒细胞白血病及其亚型的微小RNA表达[J].中华肿瘤杂志, 2011, 33(11): 831-835.？ [6]Shu M, Zheng X, Wu S, et al. Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells [J]. Mol Cancer, 2011, 10: 59.？ [7]Tavazoie S F, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis[J]. Natuer, 2008, 451(7175): 147-152.？ [8]Xu Y, Zhao F, Wang Z, et al. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1 [J]. Oncogene, 2012, 31(11): 1398-1407.？ [9]Calin G A, Dumitru C D, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci USA, 2002, 99(24): 15524-15529. [10]Makiyama K, Hamada J, Takada M, et al. Aberrant expression of HOX genes in human invasive breast carcinoma[J]. Oncol Rep, 2005, 13(4): 673-679.？ [11]Negrini M, Rasio D, Hampton G M, et al. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer : identification of a new region at 11q23.3[J]. Cancer Res, 1995, 55(14): 3003-3007.？ [12]Ma L, Teruya-Feldstein J, Weinberg R A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature, 2007, 449 (7163) : 682-688.？ [13]Wu Z S, Wu Q, Wang C Q, et al. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met[J]. Cancer, 2011, 117(13): 2842-2852.？ [14]王鹤, 刘志利, 德伟, 等. microRNA-335对人非小细胞肺癌细胞迁移、侵袭及增殖能力的影响[J]. 南京医科大学学报: 自然科学版, 2012, 32(6): 795-799.？ [15]Lee H W, Lee S S, Lee S J, et al. Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation [J]. Cancer Res, 2003, 63(5): 1093-1100.？ [16]Scharer C D, McCabe C D, Ali-Seyed M, et al. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells [J]. Cancer Res, 2009, 69(2): 709-717.？ [17]Arvelo F, Cotte C. Metalloproteinases in tumor progression. Review [J]. Invest Clin, 2006, 47(2): 185-205.？ [18]Decock J, Hendrickx W, Drijkoningen M, et al. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas [J]. Dis Markers, 2007, 23(3): 189-196.？ [19]Kim H J, Park C I, Park BW , et al. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast [J]. Yonsei Med J, 2006, 47(3): 333-342.
[2]
陈庆峰,牛兆河,刘翠翠,等.鼠-人嵌合抗粘蛋白1 IgG1全抗体的构建及其功能初步分析[J].第三军医大学学报,2012,34(17):1771. Chen Qingfeng,Niu Zhaohe,Liu Cuicui,et al.Construction and characterization of a mouse-human chimeric anti-mucin1 IgG antibody[J].J Third Mil Med Univ,2012,34(14):1771. [2]张彦,郑晓东,唐鹏,等.Sphk1基因对人乳腺癌MCF-7细胞增殖、凋亡和迁移能力的影响[J].第三军医大学学报,2012,34(21):2141. Zhang Yan,Zheng Xiaodong,Tang Peng,et al.Sphk1 interference suppresses proliferation, apoptosis and migration in human MCF-7 breast cancer cells[J].J Third Mil Med Univ,2012,34(14):2141. [3]王杨,陈彬,姜晓梅,等.睾酮对乳腺癌细胞中FEN1表达的影响[J].第三军医大学学报,2013,35(02):95. Wang Yang,Chen Bin,Jiang Xiaomei,et al.Effect of testosterone on FEN1 expression in breast cancer cells[J].J Third Mil Med Univ,2013,35(14):95. [4]李昌秀,曹友德.乳腺癌组织COX-2、VEGF-C的表达与淋巴结转移的关系[J].第三军医大学学报,2007,29(20):1964. LI Chang-xiu,CAO You-de.Correlation of COX-2 and VEGF-C expressions in breast carcinoma with lymph node metastasis[J].J Third Mil Med Univ,2007,29(14):1964. [5]周艳,姜军,张毅,等.雌激素受体β及其剪切变异体表达与雌激素受体阻滞剂治疗耐药的关系[J].第三军医大学学报,2007,29(20):1999. ZHOU Yan,JIANG Jun,ZHANG Yi,et al.Relationship of estrogen receptor-beta and its isoform expressions with tamoxifen resistance in human breast cancer[J].J Third Mil Med Univ,2007,29(14):1999. [6]陈蓉,张伟国,张连阳,等.MRI评价乳腺癌行保乳术的可行性研究[J].第三军医大学学报,2007,29(17):1712. CHEN Rong,ZHANG Wei-guo,ZHANG Lian-yang,et al.Feasibility of utilizing MRI for assessing breast-conserving surgery of breast cancer[J].J Third Mil Med Univ,2007,29(14):1712. [7]周艳,张毅,梁燕,等.乳腺癌雌激素受体β表达与临床病理及预后标志物的关系[J].第三军医大学学报,2007,29(11):1090. ZHOU Yan,ZHANG Yi,LIANG Yan,et al.Association of ERβ expression with the clinical pathologic indexes and prognostic biomarkers of breast cancer[J].J Third Mil Med Univ,2007,29(14):1090. [8]徐鹰妮,姜军,程鸿,等.ERα和ERβ在不同类型乳腺组织的表达及其意义[J].第三军医大学学报,2007,29(11):1093. XU Ying-ni,JIANG Jun,CHENG Hong,et al.Expression and significance of estrogen receptor isoforms in different breast tissues[J].J Third Mil Med Univ,2007,29(14):1093. [9]彭俊华,糜漫天,朱俊东,等.辛基酚和三羟异黄酮对二甲基苯蒽诱发大鼠乳腺肿瘤的影响[J].第三军医大学学报,2005,27(23):2317. [10]陈庆峰,马中良,王笑峰,等.抗粘蛋白1单链抗体的构建及其功能初步分析[J].第三军医大学学报,2010,32(16):1770. Chen Qingfeng,Ma Zhongliang,Wang Xiaofeng,et al.Construction and characterization of anti-mucin1 single chain Fv antibody fragment[J].J Third Mil Med Univ,2010,32(14):1770.
